Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland

被引:0
作者
Anna Dubaniewicz
Sarra E Jamieson
M Dubaniewicz-Wybieralska
Michaela Fakiola
E Nancy Miller
Jenefer M Blackwell
机构
[1] Medical University of Gdańsk,Department of Pathophysiology
[2] University of Cambridge School of Clinical Medicine,Cambridge Institute for Medical Research, Wellcome Trust/MRC Building
[3] Addenbrookes Hospital,Department of Radiology
[4] Medical University of Gdańsk,undefined
来源
European Journal of Human Genetics | 2005年 / 13卷
关键词
(formerly ; ); sarcoidosis; tuberculosis;
D O I
暂无
中图分类号
学科分类号
摘要
Sarcoidosis (SA) is a systemic granulomatous disorder of unknown etiology characterized by T helper 1-type inflammatory responses at sites of disease with signs of B cell hyperactivity. Like rheumatoid arthritis and diabetes, an infectious etiology has frequently been postulated but no single infectious trigger definitively identified. Polymorphic alleles at SLC11A1 have previously been associated with susceptibility to both the putative infectious agents and to these autoimmune disorders. We therefore investigated its candidacy as a genetic determinant of SA in Poland in an association-based study comparing 86 SA patients with 85 tuberculosis (TB) patients and 93 control subjects. The functional promoter (GT)n polymorphism and four of 10 other single nucleotide or insertion/deletion polymorphisms genotyped across SLC11A1 were informative in our sample. Consistent with previous autoimmune disease studies, allele 3 at the functional (GT)n promoter region repeat polymorphism was significantly associated with SA when compared with healthy controls (odds ratio 1.68; 95% CI: 1.01–2.81; P=0.04) or with TB patients (odds ratio 1.69; 95% CI: 1.042–0.78; P=0.03).
引用
收藏
页码:829 / 834
页数:5
相关论文
共 121 条
[1]  
Hunninghake GW(1999)Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999 Am J Respir Crit Care Med 160 736-755
[2]  
Crystal RG(1981)Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes J Clin Invest 67 86-92
[3]  
Weinberg I(2000)Anti-dsDNA antibodies in sarcoidosis Semin Arthritis Rheum 29 328-331
[4]  
Vasiliev L(1990)Autoantibodies to poly(ADP-ribose)polymerase in autoimmune diseases Autoimmunity 6 203-209
[5]  
Gotsman I(1990)Anticarbohydrate autoantibodies to sialidase-treated erythrocytes and thymocytes in serum from patients with pulmonary sarcoidosis Am J Med 88 486-492
[6]  
Negri C(1994)Sarcoidosis and Wegener's granulomatosis: a comparative analysis Sarcoidosis 11 7-18
[7]  
Scovassi AI(1970)Sarcoidosis, thyroiditis, and Addison's disease Lancet 2 330-333
[8]  
Cerino A(1983)TASS syndrome: unusual association of thyroiditis, Addison's disease, Sjogren's syndrome and sarcoidosis J Roy Soc Med 76 883-885
[9]  
Pilatte Y(1993)Polyglandular autoimmune syndrome type III associated with coeliac disease and sarcoidosis Postgrad Med J 69 72-75
[10]  
Tisserand EM(1987)Tuberculostearic acid in lymph nodes from patients with sarcoidosis Sarcoidosis 4 101-104